相关实验视频
Updated: Sep 10, 2025

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
1.2K
治疗HIF-2α抗体后的脏手术:手术指示,结果和生长动力学
Daniel Nethala1, Braden Millan1, Jason Hyman1
1Center for Cancer Research, Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Urologic oncology
|August 23, 2025
概括
在VHL缺陷癌患者接受HIF- 2α抗剂治疗后,脏手术是安全的. 在治疗期间瘤生长率没有显著变化,这表明积极的生长可能会促使早期的手术.
科学领域:
- 癌症学
- 肝脏病学
- 药理学
背景情况:
- HIF-2α抗剂代表了VHL缺陷癌的新疗法.
- 在接受HIF- 2α抗剂治疗后进行脏手术的安全性和有效性尚未得到充分证实.
- 在这种情况下,调查手术结果和瘤生长率对于患者的管理至关重要.
研究的目的:
- 在接受HIF- 2α抗剂治疗的患者中评估手术的适用性和结果.
- 评估HIF-2α抗剂对瘤生长率的影响.
- 在治疗HIF- 2α抗剂期间或之后进行脏手术的安全性和可行性.
主要方法:
- 在接受HIF- 2α抗体治疗后或治疗期间接受脏手术的患者的回顾性分析.
- 收集临床病理学数据,治疗细节和手术结果.
- 在药物注射前,药物注射期间和药物注射后计算和比较指数瘤GRs.
主要成果:
- 27名患者接受了28次手术;24名患者接受了Belzutifan,3名患者接受了PT2385,26名患者患有VHL综合征.
- 手术前治疗的中位时间为14. 7个月,药物到手术的洗期为10天.
- 在治疗前,治疗期间和治疗后阶段,瘤GR没有显著差异.
结论:
- 在暴露于HIF- 2α抗体的患者中,脏手术是安全的和可行的,并发症和输血率与标准手术相比.
- 在使用HIF- 2α抗剂治疗期间,瘤生长率没有显著变化.
- 在治疗期间瘤的增长可能表明需要在瘤达到3厘米值之前进行手术.
相关概念视频
Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Kidney Transplant III: Nursing Management
81
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
81

